135 related articles for article (PubMed ID: 6780634)
21. The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine.
Dbaibo G; Van der Wielen M; Reda M; Medlej F; Tabet C; Boutriau D; Sumbul A; Anis S; Miller JM
Int J Infect Dis; 2012 Aug; 16(8):e608-15. PubMed ID: 22704725
[TBL] [Abstract][Full Text] [Related]
22. Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine.
Milagres LG; Gorla MC; Rebelo MC; Barroso DE
FEMS Immunol Med Microbiol; 2000 Aug; 28(4):319-27. PubMed ID: 10891656
[TBL] [Abstract][Full Text] [Related]
23. Long-term persistence of protective antibodies in Dutch adolescents following a meningococcal serogroup C tetanus booster vaccination.
van Ravenhorst MB; Marinovic AB; van der Klis FR; van Rooijen DM; van Maurik M; Stoof SP; Sanders EA; Berbers GA
Vaccine; 2016 Dec; 34(50):6309-6315. PubMed ID: 27817957
[TBL] [Abstract][Full Text] [Related]
24. Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide.
Peltola H; Käyhty H; Kuronen T; Haque N; Sarna S; Mäkelä PH
J Pediatr; 1978 May; 92(5):818-22. PubMed ID: 417160
[TBL] [Abstract][Full Text] [Related]
25. Response of children to Neisseria meningitidis polysaccharide vaccines.
Monto AS; Brandt BL; Artenstein MS
J Infect Dis; 1973 Apr; 127(4):394-400. PubMed ID: 4632878
[No Abstract] [Full Text] [Related]
26. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
Cui XL; Wu X; Li MQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
[No Abstract] [Full Text] [Related]
27. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
Wu C
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
[No Abstract] [Full Text] [Related]
28. Further characterization of responses of infants and children to meningococcal A polysaccharide vaccine.
Wilkins J; Wehrle PF
J Pediatr; 1979 May; 94(5):828-32. PubMed ID: 109592
[TBL] [Abstract][Full Text] [Related]
29. Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay.
Leinonen M; Frasch CE
Infect Immun; 1982 Dec; 38(3):1203-7. PubMed ID: 6818147
[TBL] [Abstract][Full Text] [Related]
30. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
[TBL] [Abstract][Full Text] [Related]
31. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
32. Seroconversion and duration of immunity after vaccination against group C meningococcal infection in young children.
Espín Ríos I; García-Fulgueíras A; Navarro Alonso JA; Vazquez Moreno J; Rodriguez Gonzalez T; Navarro Sánchez C; Pérez-Flores D
Vaccine; 2000 Jun; 18(24):2656-60. PubMed ID: 10781851
[TBL] [Abstract][Full Text] [Related]
33. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
34. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Knol MJ; Stoof SP; Sanders EAM; Berbers GAM
Vaccine; 2017 Aug; 35(36):4745-4752. PubMed ID: 28668575
[TBL] [Abstract][Full Text] [Related]
35. Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination.
Block SL; Christensen S; Verma B; Xie F; Keshavan P; Dull PM; Smolenov I
Vaccine; 2015 Apr; 33(18):2175-82. PubMed ID: 25744224
[TBL] [Abstract][Full Text] [Related]
36. Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants.
Poellabauer EM; Pavlova BG; Fritsch S; Singer J; Neubauer C; Doralt J; Valenta-Singer B; Ehrlich HJ
Vaccine; 2013 Aug; 31(35):3611-6. PubMed ID: 23672977
[TBL] [Abstract][Full Text] [Related]
37. The unspecific antibody response to N. meningitidis group A capsular polysaccharide often seen in bacteraemic diseases.
Käyhty H
Parasite Immunol; 1982 May; 4(3):157-70. PubMed ID: 6808441
[TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
[TBL] [Abstract][Full Text] [Related]
39. Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine.
de Whalley PC; Snape MD; Kelly DF; Banner C; Lewis S; Diggle L; John TM; Yu LM; Omar O; Borkowski A; Pollard AJ
Pediatr Infect Dis J; 2011 Nov; 30(11):e203-8. PubMed ID: 21673612
[TBL] [Abstract][Full Text] [Related]
40. Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy.
McCormick JB; Gusmão HH; Nakamura S; Freire JB; Veras J; Gorman G; Feeley JC; Wingo P
J Clin Invest; 1980 May; 65(5):1141-4. PubMed ID: 6767739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
